Browse > Article
http://dx.doi.org/10.5483/BMBRep.2013.46.7.018

Neuroprotective effects of the antioxidant action of 2-cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride against ischemic neuronal damage in the brain  

Ha, Seung Cheol (Department of Biochemistry and Molecular Biology, University of Ulsan College of Medicine)
Han, A Reum (Department of Biochemistry and Molecular Biology, University of Ulsan College of Medicine)
Kim, Dae Won (Department of Biomedical Science, Research Institute for Bioscience and Biotechnology, and Medical & Bio-material Research Center, Hallym University)
Kim, Eun-A (Department of Biochemistry and Molecular Biology, University of Ulsan College of Medicine)
Kim, Duk-Soo (Department of Anatomy, College of Medicine, Soonchunhyang University)
Choi, Soo Young (Department of Biomedical Science, Research Institute for Bioscience and Biotechnology, and Medical & Bio-material Research Center, Hallym University)
Cho, Sung-Woo (Department of Biochemistry and Molecular Biology, University of Ulsan College of Medicine)
Publication Information
BMB Reports / v.46, no.7, 2013 , pp. 370-375 More about this Journal
Abstract
Ischemia is characterized by oxidative stress and changes in the antioxidant defense system. Our recent in vitro study showed that 2-cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride protects cortical astrocytes against oxidative stress. In the current study, we examined the effects of 2-cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride on ischemia-induced neuronal damage in a gerbil ischemia/reperfusion models. Extensive neuronal death in the hippocampal CA1 area was observed 4 days after ischemia/reperfusion. Intraperitoneal injection of 2-cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride (0.3 mg/kg body weight) significantly prevented neuronal death in the CA1 region of the hippocampus in response to transient forebrain ischemia. 2-Cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride administration reduced ischemia-induced increases in reactive oxygen species levels and malondialdehyde content. It also attenuated the associated reductions in glutathione level and superoxide dismutase, catalase, and glutathione peroxidase activities. Taken together, our results suggest that 2-cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride protects against ischemia-induced neuronal damage by reducing oxidative stress through its antioxidant actions.
Keywords
Antioxidative agent; Ischemia; Oxidative stress; Reactive oxygen species; 2-cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Heiser, V., Engemann, S., Brocker, W., Dunkel, I., Boeddrich, A., Waelter, S., Nordhoff, E., Lurz, R., Schugardt, N., Rautenberg, S., Herhaus, C., Barnickel, G., Bottcher, H., Lehrach, H. and Wanker, E. E. (2002) Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay. Proc. Natl. Acad. Sci. U.S.A. 99, 16400-16406.   DOI   ScienceOn
2 Kim, D. W., Jeong, H. J., Kang, H. W., Shin, M. J., Sohn, E. J., Kim, M. J., Ahn, E. H., An, J. J., Jang, S. H., Yoo, K. Y., Won, M. H., Kang, T. C., Hwang, I. K., Kwon, O. S., Cho, S. W., Park, J., Eum, W. S. and Choi, S. Y. (2009) Transduced human PEP-1-catalase fusion protein attenuates ischemic neuronal damage. Free Radic. Biol. Med. 47, 941-952.   DOI   ScienceOn
3 Vieira, H. L., Belzacq, A. S. and Haouzi, D. (2001) The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal. Oncogene 20, 4305-4316.   DOI
4 Candelario-Jalil, E., Mhadu, N. H., Al-Dalain, S. M., Martinez, G. and Leon, O. S. (2001) Time course of oxidative damage in different brain regions following transient cerebral ischemia in gerbils. Neurosci. Res. 41, 233-241.   DOI   ScienceOn
5 Wang, Q., Sun, A. Y., Simonyi, A., Jensen, M. D., Shelat, P. B., Rottinghaus, G. E., MacDonald, R. S., Miller, D. K., Lubahn, D. E., Weisman, G. A. and Sun, G. Y. (2005) Neuroprotective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits. J. Neurosci. Res. 82, 138-148.   DOI   ScienceOn
6 Sharma, S. S., Dhar, A. and Kaundal, R. K. (2007) FeTPPS protects against global cerebral ischemic-reperfusion injury in gerbils. Pharmacol. Res. 55, 335-342.   DOI   ScienceOn
7 Dringen, R. (2000) Metabolism and functions of glutathione in brain. Prog. Neurobiol. 62, 649-671.   DOI   ScienceOn
8 Schulz, J. B., Lindenau, J., Seyfried, J. and Dichgans, J. (2000) Glutathione, oxidative stress and neurodegeneration. Eur. J. Biochem. 267, 4904-4911.   DOI   ScienceOn
9 Flohe, L. and Ginzler, W. A. (1984) Assay of glutathione peroxidase. Methods Enzymol. 105, 114-121.   DOI   ScienceOn
10 Lombardi, G., Varsaldi, F., Miglio, G., Papini, M. G., Battaglia, A. and Canonico, P. L. (2002) Cabergoline prevents necrotic neuronal death in an in vitro model of oxidative stress. Eur. J. Pharmacol. 457, 95-99.   DOI   ScienceOn
11 Aebi, H. (1984) Catalase in vitro. Methods Enzymol. 105, 121-126.   DOI   ScienceOn
12 Li, P. S., He, Q. P., Nakamura, L. and Csiszar, K. (2001) Free radical spin trap ${\alpha}$-phenyl-N-tertbutyl-nitron inhibits caspase-3 activation and reduces brain damage following a severe forebrain ischemic injury. Free Radic. Biol. Med. 31, 1191-1197.   DOI   ScienceOn
13 Beal, M. F., Hyman, B. T. and Koroshetz, W. (1993) Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci. 16, 125-131.   DOI   ScienceOn
14 Mortimer, C. G., Wells, G., Crochard, J. P., Stone, E. L., Bradshaw, T. D., Stevens, M. F. G. and Westwell, A. D. (2006) Antitumor Benzothiazoles. 26.1 2-(3,4-Dimethoxyphenyl)- 5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines. J. Med. Chem. 49, 179-185.   DOI   ScienceOn
15 Pietrancosta, N., Moumen, A., Dono, R., Lingor, P., Planchamp, V., Lamballe, F., Bahr, M., Kraus, J. L. and Maina, F. (2006) Imino-tetrahydro-benzothiazole derivatives as p53 inhibitors : discovery of a highly potent in vivo inhibitor and its action mechanism. J. Med. Chem. 49, 3645-3652.   DOI   ScienceOn
16 Carboni, S., Hiver, A., Szyndralewiez, C., Gaillard, P., Gotteland, J. P. and Vitte, P. A. (2004) AS601245 (1,3- benzothiazol-2-yl (2-[[2-(3-pyridinyl) ethyl] amino]-4 pyrimidinyl) acetonitrile): a c-Jun NH2-terminal protein kinase inhibitor with neuroprotective properties. J. Pharmacol. Exp. Ther. 310, 25-32.   DOI   ScienceOn
17 Chan, P. H. (1996) Role of oxidants in ischemic brain damage. Stroke 27, 1124-1129.   DOI   ScienceOn
18 Small, D. L. and Buchan, A. M. (2000) Animal models. Br. Med. Bull. 56, 307-317.   DOI   ScienceOn
19 McKracken, E., Graham, D. I., Nilsen, M., Stewart, J., Nicoll, J. A. and Horsburgh, K. (2001) 4-Hydroxynonenal immunoreactivity is increased in human hippocampus after global ischemia. Brain Pathol. 11, 414-421.   DOI   ScienceOn
20 Kim, D. W., Kim, D.-S., Kim, M. J., Kwon, S. W., Ahn, E. H., Jeong, H. J., Sohn, E. J., Dutta, S., Lim, S. S., Cho, S. -W., Lee, K. S., Park, J., Eum, W. S., Hwang, H. S. and Choi, S. Y. (2011) Imipramine enhances neuroprotective effect of PEP-1-Catalase against ischemic neuronal damage. BMB Rep. 44, 647-652.   과학기술학회마을   DOI   ScienceOn
21 Piantadosi, C. A. and Zhang, J. (1996) Mitochondrial generation of reactive oxygen species after brain ischemia in the rat. Stroke 27, 327-331.   DOI   ScienceOn
22 Liu, D., Smith, C. L., Barone, F. C., Ellison, J. A., Lysko, P. G., Li, K. and Simpson, I. A. (1999) Astrocytic demise precedes delayed neuronal death in focal ischemic rat brain. Mol. Brain Res. 68, 29-41.   DOI   ScienceOn
23 Schreibelt, G., Horssen, J. V., Rossum, S. V., Dijkstra, C. D., Drukarch, B. and Vries, H. E. (2007) Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology. Brain Res. Rev. 56, 322-330.   DOI   ScienceOn
24 Choi, M. M., Kim, E. A., Hahn, H. G., Nam, K. D., Yang, S. J., Choi, S. Y., Kim, T. U., Cho, S. W. and Huh, J. W. (2007) Protective effect of benzothiazole derivative KHG21834 on amyloid beta-induced neurotoxicity in PC12 cells and cortical and mesencephalic neurons. Toxicology 239, 156-166.   DOI   ScienceOn
25 Kim, E. A., Hahn, H. G., Kim, K. S., Kim, T. U., Choi, S. Y. and Cho, S.-W. (2010) Suppression of glutamate-induced excitotoxicity by 2-cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride in rat glial cultures. Cell. Mol. Neurobiol. 30, 807-815.   DOI   ScienceOn
26 Ishiyama, T., Okada, R., Nishibe, H., Mitsumoto, H. and Nakayama, C. (2004) Riluzole slows the progression of neuromuscular dysfunction in the wobbler mouse motor neuron disease. Brain Res. 1019, 226-236.   DOI   ScienceOn
27 Kim, E. A., Hahn, H. G., Kim, T. U., Choi, S. Y. and Cho, S.-W. (2010) Attenuation of ${\beta}$-amyloid-induced neuroinflammation by KHG21834 in vivo. BMB Rep. 43, 413-418.   과학기술학회마을   DOI   ScienceOn
28 Kim, H., Son, H. J., Ha, S. C., Kim, E. A., Kim, T. U., Choi, S. Y., Ahn, J. Y. and Cho, S. W. (2011) Neuroprotective effects of 2-cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride against oxidative stress. Cell. Mol. Neurobiol. 31, 979-984.   DOI   ScienceOn
29 Urbani, A. and Belluzzi, O. (2000) Riluzole inhibits the persistent sodium current in mammalian CNS neurons. Eur. J. Neurosci. 12, 3567-3574.   DOI   ScienceOn
30 Brantley, E., Antony, S., Kohlhagen, G., Meng, L. H., Agama, K., Stinson, S. F., Sausville, E. A. and Pommier, Y. (2006) Anti-tumor drug candidate 2-(4-amino-3-methyl-phenyl)-5-fluorobenzothiazole induces single-strand breaks and DNA-protein cross-links in sensitive MCF-7 breast cancer cells. Cancer Chemother. Pharmacol. 58, 62-72.   DOI
31 Oostveen, J. A., Dunn, E., Carter, D. B. and Hall, E. D. (1998) Neuroprotective efficacy and mechanisms of novel pyrrolopyrimidine lipid peroxidation inhibitors in the gerbil forebrain ischemia model. J. Cereb. Blood Flow Metab. 18, 539-547.   DOI
32 Floyd, R. A. (1990) Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J. 4, 2587-2597.   DOI
33 Sayre, L. M., Perry, G. and Smith, M. A. (2008) Oxidative stress and neurotoxicity. Chem. Res. Toxicol. 21, 172-188.   DOI   ScienceOn
34 Petito, C. K., Torres-Munoz, J., Roberts, B., Olarte, J. P., Nowak, Jr., T. S. and Pulsinelli, W. A. (1997) DNA fragmentation follows delayed neuronal death in CA1 neurons exposed to transient global ischemia in the rat. J. Cereb. Blood Flow. Metab. 17, 967-976.
35 Frantseva, M. V., Carlen, P. L. and Perez Velazquez, J. L. (2001) Dynamics of intracellular calcium and free radical production during ischemia in pyramidal neurons. Free Radic. Biol. Med. 31, 1216-1227.   DOI   ScienceOn
36 Dore, S., Otsuka, T., Mito, T., Sugo, N., Hand, T., Wu, L., Hurn, P. D., Traystman, R. J. and Andreasson, K. (2003) Neuronal overexpression of cyclooxygenase-2 increases cerebral infarction. Ann. Neurol. 5, 155-162.
37 Fallarini, S., Miglio, G., Paoletti, T., Minassi, A., Amoruso, A., Bardelli, C., Brunelleschi, S. and Lombardi, G. (2009) Clovamide and rosmarinic acid induce neuroprotective effects in vitro models of neuronal death. Br. J. Pharmacol. 15, 1072-1084.
38 Trushina, E. and McMurray, C. T. (2007) Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience 145, 1233-1248.   DOI   ScienceOn
39 Margaill, I., Plotkine, M. and Lerouet, D. (2005) Antioxidant strategies in the treatment of stroke. Free Radic. Biol. Med. 39, 429-443.   DOI   ScienceOn